Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07769905Phase 1Not yet recruiting
Phase 1, open-label trial (2 arms), sponsored by NYU Langone Health. Primary endpoints: Providers that observed increased mucosal visibility at Day 1, Providers who observed a reduction colonic spasm at Day 1 and 1 more. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07769905.